Diabetes complications

Association between estimated glucose disposal rate and lower extremity arterial disease in type 2 diabetes: A nationwide cross‐sectional study from China

Diabetes Obes MetabPublished Cross-sectional study

Authors' conclusion

eGDR demonstrated a significant inverse L-shaped association with LEAD in patients with T2DM. These findings support the clinical utility of eGDR as a practical indicator of LEAD risk screening and management. Patients with lower eGDR may benefit from insulin-sensitising therapies, which could reduce both glucose levels and the risk of LEAD.

Study context

Population
Adults aged ≥50 years with T2D, China DIA-LEAD study
Participants
7,482 adults
Exposure
Estimated glucose disposal rate (eGDR) quartiles
Outcome
LEAD, defined by ankle-brachial index <0.9 or >1.3
Methodological detailsnationwide, multivariate logistic regression, restricted cubic spline models
  • Nationwide
  • Multivariate logistic regression
  • Restricted cubic spline models

Main finding

As reported in the abstract

LEAD
Adjusted odds ratio (95% CI)
Per 1-unit eGDR increase24% lower LEAD risk
0.76(0.70–0.84)

Per 1-unit eGDR increase, as printed

Q1 vs Q4 · fully adjusted
fold higher lower extremity arterial disease (LEAD) risk 2.23 (95% CI 1.47–3.37)
Progressively higher LEAD prevalence in lower eGDR quartiles
all p < 0.001
L-shaped relationship, sharp risk escalation at eGDR < 8 mg/kg/min
p for nonlinearity = 0.003

Observational data: associations, not effects.

Further findings

HbA1c

HbA1c — Worse glycaemic control and greater comorbidity burden in lower quartiles
all p < 0.001

Subgroup analyses

Consistency across populations
all p for interaction >0.05

Original publication

Association between estimated glucose disposal rate and lower extremity arterial disease in type 2 diabetes: A nationwide cross‐sectional study from China. Diabetes Obes Metab. Published 9 June 2025. doi:10.1111/dom.16514

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.